Perpetua Medical AB (publ) (STO:PERP.B)
Sweden
· Delayed Price · Currency is SEK 4.420
-0.170 (-3.70%)
At close: Jun 13, 2025
Perpetua Medical AB Income Statement
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Revenue | 8.79 | 6.94 | 9.94 | 10.11 | 8.82 | 1.9 | Upgrade
|
| Revenue Growth (YoY) | 33.63% | -30.16% | -1.76% | 14.73% | 363.72% | -12.86% | Upgrade
|
| Cost of Revenue | 5.13 | 3.8 | 4.09 | 3.47 | 2.89 | 0.96 | Upgrade
|
| Gross Profit | 3.66 | 3.14 | 5.85 | 6.65 | 5.93 | 0.94 | Upgrade
|
| Selling, General & Admin | 9.38 | 10.94 | 23.78 | 25.56 | 19.37 | 15.73 | Upgrade
|
| Other Operating Expenses | -0.83 | -5.66 | 0.38 | -0.19 | -0.14 | -0.77 | Upgrade
|
| Operating Expenses | 9.17 | 5.6 | 24.34 | 25.76 | 19.61 | 15.46 | Upgrade
|
| Operating Income | -5.51 | -2.46 | -18.49 | -19.11 | -13.68 | -14.51 | Upgrade
|
| Interest Expense | -0.17 | -0.08 | -0.07 | -0.13 | -0.15 | -0.15 | Upgrade
|
| Interest & Investment Income | 0.22 | 0.29 | 0.29 | 0.07 | 0.12 | 0.07 | Upgrade
|
| Other Non Operating Income (Expenses) | 0 | - | - | -0 | - | - | Upgrade
|
| EBT Excluding Unusual Items | -5.46 | -2.24 | -18.28 | -19.16 | -13.71 | -14.59 | Upgrade
|
| Gain (Loss) on Sale of Assets | 0.04 | 0.04 | - | - | - | - | Upgrade
|
| Pretax Income | -5.42 | -2.2 | -18.28 | -19.16 | -13.71 | -14.59 | Upgrade
|
| Income Tax Expense | 0.32 | 0.18 | - | - | - | - | Upgrade
|
| Earnings From Continuing Operations | -5.74 | -2.38 | -18.28 | -19.16 | -13.71 | -14.59 | Upgrade
|
| Minority Interest in Earnings | -0.16 | -0.09 | - | - | - | - | Upgrade
|
| Net Income | -5.9 | -2.47 | -18.28 | -19.16 | -13.71 | -14.59 | Upgrade
|
| Net Income to Common | -5.9 | -2.47 | -18.28 | -19.16 | -13.71 | -14.59 | Upgrade
|
| Shares Outstanding (Basic) | 5 | 4 | 2 | 1 | 1 | 0 | Upgrade
|
| Shares Outstanding (Diluted) | 5 | 4 | 2 | 1 | 1 | 0 | Upgrade
|
| Shares Change (YoY) | 89.80% | 145.32% | 153.20% | 20.61% | 20.91% | 31.09% | Upgrade
|
| EPS (Basic) | -1.30 | -0.58 | -10.56 | -28.03 | -24.18 | -31.11 | Upgrade
|
| EPS (Diluted) | -1.30 | -0.58 | -10.56 | -28.03 | -24.18 | -31.11 | Upgrade
|
| Free Cash Flow | -4.98 | -7.03 | -16.41 | -19.65 | -15.84 | -13.58 | Upgrade
|
| Free Cash Flow Per Share | -1.10 | -1.66 | -9.48 | -28.74 | -27.94 | -28.95 | Upgrade
|
| Gross Margin | 41.66% | 45.27% | 58.85% | 65.72% | 67.26% | 49.68% | Upgrade
|
| Operating Margin | -62.64% | -35.39% | -186.11% | -188.94% | -155.22% | -763.45% | Upgrade
|
| Profit Margin | -67.04% | -35.64% | -183.94% | -189.48% | -155.54% | -767.33% | Upgrade
|
| Free Cash Flow Margin | -56.59% | -101.27% | -165.16% | -194.31% | -179.68% | -714.17% | Upgrade
|
| EBITDA | -5.19 | -2.13 | -18.31 | -18.72 | -13.3 | -14.01 | Upgrade
|
| EBITDA Margin | -59.04% | -30.73% | -184.31% | -185.10% | -150.87% | - | Upgrade
|
| D&A For EBITDA | 0.32 | 0.32 | 0.18 | 0.39 | 0.38 | 0.5 | Upgrade
|
| EBIT | -5.51 | -2.46 | -18.49 | -19.11 | -13.68 | -14.51 | Upgrade
|
| EBIT Margin | -62.64% | -35.39% | -186.11% | -188.94% | -155.22% | - | Upgrade
|
| Revenue as Reported | 10.33 | 14.15 | 9.98 | 10.42 | 9 | 2.77 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.